Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
20.20B | 19.93B | 21.00B | 19.93B | 31.84B | Gross Profit |
1.78B | 1.72B | 1.61B | 1.44B | 1.66B | EBIT |
162.61M | 122.14M | 25.87M | -48.04M | 11.31M | EBITDA |
284.87M | 306.59M | 146.57M | 78.60M | 133.38M | Net Income Common Stockholders |
181.12M | 162.66M | 54.21M | 11.10M | 62.02M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
593.89M | 942.93M | 414.83M | 253.62M | 621.13M | Total Assets |
5.41B | 5.59B | 5.47B | 4.63B | 4.58B | Total Debt |
501.00M | 667.30M | 920.20M | 100.00M | 200.00M | Net Debt |
-92.89M | -275.63M | 511.37M | -153.62M | -421.13M | Total Liabilities |
2.89B | 3.23B | 3.30B | 2.50B | 2.48B | Stockholders Equity |
2.52B | 2.36B | 2.17B | 2.13B | 2.10B |
Cash Flow | Free Cash Flow | |||
49.69M | 816.90M | -652.74M | -222.81M | 373.21M | Operating Cash Flow |
133.78M | 888.93M | 110.63M | -203.21M | 397.28M | Investing Cash Flow |
-297.73M | -82.98M | -756.78M | -45.56M | -17.84M | Financing Cash Flow |
-185.10M | -271.84M | 801.35M | -118.75M | -219.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥18.74B | 4.03 | 2.84% | 5.07% | 24.86% | ||
72 Outperform | ¥52.63B | 23.89 | 0.59% | 13.62% | 24.54% | ||
70 Outperform | ¥27.28B | 19.27 | 0.90% | -0.54% | -13.51% | ||
65 Neutral | $8.92B | 15.03 | 4.68% | 6.11% | 3.59% | -2.49% | |
63 Neutral | ¥3.75B | 20.69 | 0.50% | 1.40% | 11.35% | ||
61 Neutral | ¥51.89B | 13.13 | 2.72% | 1.11% | ― | ||
59 Neutral | ¥4.10B | 145.41 | 1.01% | 7.64% | -71.33% |